We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
PainReform Ltd | NASDAQ:PRFX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.03 | -3.70% | 0.78 | 0.7215 | 2.50 | 0.8499 | 0.78 | 0.791 | 14,683 | 05:00:02 |
1.
|
A copy of the Notice and Proxy Statement with respect to the Company’s Extraordinary General Meeting of Shareholders describing the proposals to be voted upon at the meeting, the procedure
for voting in person or by proxy at the meeting and various other details related to the meeting, attached hereto as Exhibit 99.1; and
|
2.
|
A form of Proxy Card whereby holders of ordinary shares of the Company may vote at the meeting without attending in person, attached hereto as Exhibit 99.2.
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
|
Date: March 7, 2024
|
PAINREFORM LTD.
|
|
|
|
|
|
By:
|
/s/ Ilan Hadar
|
|
|
Ilan Hadar
|
|
|
Chief Executive Officer
|
1.
|
To approve an increase the Company’s authorized share capital by 15,000,000 shares, such that following the increase, the authorized share capital shall equal NIS 6,000,000 divided into
20,000,000 ordinary shares, par value NIS 0.3 each, and to approve an amendment to the Company’s Articles of Association accordingly.
|
|
☐
|
for
|
☐
|
against
|
☐
|
abstain
|
|
☐
|
Yes
|
☐
|
No
|
2.
|
To ratify an amendment to the Company’s compensation policy as proposed within the Board of Directors resolution dated as of November 27, 2023 with respect to the adoption of a new
clawback policy, so that when so adopted such Clawback policy will be attached as an exhibit to the Company’s Compensation Policy and form an integral part thereof, intended to comply with the clawback-related listing standards proposed
by the Nasdaq Stock Market and the Israeli Companies Law 5759-1999, as amended, to take effect upon the effective date of the Nasdaq listing rule
|
|
☐
|
for
|
☐
|
against
|
☐
|
abstain
|
|
☐
|
Yes
|
☐
|
No
|
|
|
Date: ________, 2024
|
|
|
|
Date_________, 2024
|
SIGNATURE
|
|
|
|
SIGNATURE
|
|
|
1 Year PainReform Chart |
1 Month PainReform Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions